This company listing is no longer active
METabolic EXplorer Balance Sheet Health
Financial Health criteria checks 2/6
METabolic EXplorer has a total shareholder equity of €95.1M and total debt of €116.3M, which brings its debt-to-equity ratio to 122.3%. Its total assets and total liabilities are €258.4M and €163.2M respectively.
Key information
122.3%
Debt to equity ratio
€116.31m
Debt
| Interest coverage ratio | n/a |
| Cash | €47.91m |
| Equity | €95.13m |
| Total liabilities | €163.23m |
| Total assets | €258.36m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 7ME's short term assets (€147.6M) exceed its short term liabilities (€67.3M).
Long Term Liabilities: 7ME's short term assets (€147.6M) exceed its long term liabilities (€96.0M).
Debt to Equity History and Analysis
Debt Level: 7ME's net debt to equity ratio (71.9%) is considered high.
Reducing Debt: 7ME's debt to equity ratio has increased from 13.2% to 122.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if 7ME has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 7ME has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.